The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016
Preferred Name

fesoterodine

Synonyms

2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate

C26H37NO3

ID

http://purl.obolibrary.org/obo/dinto_DB06702

AHFScode

12:08.08

ATCCode

G04BD11

blocks

http://purl.obolibrary.org/obo/dinto_3182

http://purl.obolibrary.org/obo/dinto_1005

http://purl.obolibrary.org/obo/dinto_0703

http://purl.obolibrary.org/obo/dinto_3887

http://purl.obolibrary.org/obo/dinto_2097

CASRN

286930-03-8

DBBrand

toviaz

DBSalt

fesoterodine fumarate

DBSynonym

feso

Definition

Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.

has effect

http://purl.obolibrary.org/obo/OAE_0000496

http://purl.obolibrary.org/obo/OAE_0000453

http://purl.obolibrary.org/obo/OAE_0001373

http://purl.obolibrary.org/obo/OAE_0000902

http://purl.obolibrary.org/obo/OAE_0000376

http://purl.obolibrary.org/obo/OAE_0000406

http://purl.obolibrary.org/obo/OAE_0001509

http://purl.obolibrary.org/obo/OAE_0000443

http://purl.obolibrary.org/obo/OAE_0001489

http://purl.obolibrary.org/obo/OAE_0001369

http://purl.obolibrary.org/obo/OAE_0000373

http://purl.obolibrary.org/obo/OAE_0000600

http://purl.obolibrary.org/obo/OAE_0000455

http://purl.obolibrary.org/obo/OAE_0001105

http://purl.obolibrary.org/obo/OAE_0000498

http://purl.obolibrary.org/obo/OAE_0000084

http://purl.obolibrary.org/obo/OAE_0000584

http://purl.obolibrary.org/obo/OAE_0002206

http://purl.obolibrary.org/obo/OAE_0000414

http://purl.obolibrary.org/obo/OAE_0002122

http://purl.obolibrary.org/obo/OAE_0000505

http://purl.obolibrary.org/obo/OAE_0000602

http://purl.obolibrary.org/obo/OAE_0000362

http://purl.obolibrary.org/obo/OAE_0000296

http://purl.obolibrary.org/obo/OAE_0000374

http://purl.obolibrary.org/obo/OAE_0000358

http://purl.obolibrary.org/obo/OAE_0000885

http://purl.obolibrary.org/obo/OAE_0000402

has pharmacological target

http://purl.obolibrary.org/obo/dinto_1005

InChI

InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1

InChIKey

InChIKey=DCCSDBARQIPTGU-HSZRJFAPSA-N

is metabolised by

http://purl.obolibrary.org/obo/dinto_2993

http://purl.obolibrary.org/obo/dinto_0901

is transported by

http://purl.obolibrary.org/obo/dinto_1440

label

fesoterodine

may interact with

http://purl.obolibrary.org/obo/dinto_DB00196

http://purl.obolibrary.org/obo/CHEBI_681850

http://purl.obolibrary.org/obo/dinto_DB01026

prefixIRI

obo2:dinto_DB06702

prefLabel

fesoterodine

SMILES

CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C

Synonym

2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate

C26H37NO3

xref

Wikipedia:http://en.wikipedia.org/wiki/Fesoterodine

Drugs.com:http://www.drugs.com/cdi/fesoterodine.html

RxList:http://www.rxlist.com/toviaz-drug.htm

PubChem Compound:6918558

ChemSpider:5293755

PubChem Substance:99443256

National Drug Code Directory:54868-6175-0

PharmGKB:PA165958376

subClassOf

http://purl.obolibrary.org/obo/dinto_000055

Delete Subject Author Type Created
No notes to display